DARATUMUMAB, A NOVEL HUMAN CD38 MONOCLONAL ANTIBODY FOR THE TREATMENT OF B-CELL NON-HODGKIN LYMPHOMA

被引：0
|
作者：
Matas-Cespedes, A. [1 ]
Vidal-Crespo, A. [1 ]
Rodriguez, V. [1 ]
Rossi, C. [2 ]
Roue, G. [1 ]
Lopez-Guillermo, A. [3 ]
Gine, E. [3 ]
Wiestner, A. [4 ]
Bezombes, C. [2 ]
Campo, E. [5 ]
Colomer, D. [5 ]
Balasubramanian, S. [6 ]
Chiu, C. [6 ]
Doshi, P. [6 ]
Perez-Galan, P. [1 ]
机构：
[1] IDIBAPS, Hematol Oncol, Barcelona, Spain
[2] CRCT, Hematol Oncol, Toulouse, France
[3] Hosp Clin Barcelona, Hematol, Barcelona, Spain
[4] NIH, Hematol, Bldg 10, Bethesda, MD 20892 USA
[5] Hosp Clin Barcelona, Pathol, Barcelona, Spain
[6] Janssen, R&D, Spring House, PA USA
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1369
引用
收藏
页码：563 / 563
页数：1
相关论文
共 50 条
  • [1] Treatment of B-cell non-Hodgkin's lymphoma with anti CD 20 monoclonal antibody Rituximab
    Sacchi, S
    Federico, M
    Dastoli, G
    Fiorani, C
    Vinci, G
    Clò, V
    Casolari, B
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2001, 37 (01) : 13 - 25
  • [2] Activated T-cell-mediated Immunotherapy With a Chimeric Receptor Against CD38 in B-cell Non-Hodgkin Lymphoma
    Mihara, Keichiro
    Yanagihara, Kazuyoshi
    Takigahira, Misato
    Imai, Chihaya
    Kitanaka, Akira
    Takihara, Yoshihiro
    Kimura, Akiro
    JOURNAL OF IMMUNOTHERAPY, 2009, 32 (07) : 737 - 743
  • [3] Drug therapy: Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma
    Cheson, Bruce D.
    Leonard, John P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (06): : 613 - 626
  • [4] Antibody therapy of non-Hodgkin's B-cell lymphoma
    Paul Chinn
    Gary Braslawsky
    Christine White
    Nabil Hanna
    Cancer Immunology, Immunotherapy, 2003, 52 : 257 - 280
  • [5] Antibody therapy of non-Hodgkin's B-cell lymphoma
    Chinn, P
    Braslawsky, G
    White, C
    Hanna, N
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2003, 52 (05) : 257 - 280
  • [6] Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma
    Moreau, Philippe
    van de Donk, Niels W. C. J.
    Miguel, Jesus San
    Lokhorst, Henk
    Nahi, Hareth
    Ben-Yehuda, Dina
    Cavo, Michele
    Cook, Gordon
    Delforge, Michel
    Einsele, Hermann
    Zweegman, Sonja
    Ludwig, Heinz
    Driessen, Christoph
    Palumbo, Antonio
    Facon, Thierry
    Plesner, Torben
    Dimopoulos, Meletios
    Sondergeld, Pia
    Sonneveld, Pieter
    Mateos, Maria-Victoria
    DRUGS, 2016, 76 (08) : 853 - 867
  • [7] Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma
    Philippe Moreau
    Niels W. C. J. van de Donk
    Jesus San Miguel
    Henk Lokhorst
    Hareth Nahi
    Dina Ben-Yehuda
    Michele Cavo
    Gordon Cook
    Michel Delforge
    Hermann Einsele
    Sonja Zweegman
    Heinz Ludwig
    Christoph Driessen
    Antonio Palumbo
    Thierry Facon
    Torben Plesner
    Meletios Dimopoulos
    Pia Sondergeld
    Pieter Sonneveld
    María-Victoria Mateos
    Drugs, 2016, 76 : 853 - 867
  • [8] First monoclonal antibody approved to treat relapsed B-cell Non-Hodgkin's lymphoma
    不详
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (04) : 431 - 432
  • [9] Radioimmunotherapy: A novel treatment modality for B-cell non-Hodgkin's lymphoma
    Juweid, M
    DeNardo, GL
    Graham, M
    Vose, J
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2003, 18 (05) : 673 - 674
  • [10] Monoclonal antibody therapy in the treatment of non-Hodgkin lymphoma
    McCune, SL
    Gockerman, JP
    Rizzieri, DA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (10): : 1149 - 1152
12345